Menu

Image of the Day: Frog Leaps Away from Extinction 

A once critically endangered species of leaf frog has made a comeback. 

Jan 3, 2018
The Scientist Staff, The Scientist Staff

The black-eyed leaf frog, Agalychnis moreletii, in its native habitat in GuatemalaROBIN MOORE, GLOBAL WILDLIFE CONSERVATION The black-eyed leaf frog (Agalychnis moreletii) was once listed as critically endangered on the IUCN Red List of Threatened Species, which is often the last step before complete extinction. But 13 years later, in a reevaluation of extinction risk of amphibians—supported by Global Wildlife Conservation—researchers found that the frog has made a comeback. They found the animal in historical as well as new locations in high abundances throughout its native range from Mexico to Honduras, and re-classified the frog as a species of least concern on the IUCN Red List.  

The animal was among 40 species in the evaluation whose extinction risk was downgraded. However, researchers found 23 other species to be at a higher risk of extinction than previously thought. This includes the Rio Cosnipata robber frog (Pristimantis cosnipatae), a Peruvian species that was last seen in 1999 and is considered possibly extinct. 

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.